+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

From
From
From
From
From
From
Anti-Obesity Drugs Markets in China - Product Thumbnail Image

Anti-Obesity Drugs Markets in China

  • Report
  • November 2023
  • 211 Pages
  • China
From
From
From
Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Obesity. Global Impact and Epidemiology - Product Thumbnail Image

Obesity. Global Impact and Epidemiology

  • Book
  • July 2020
  • Global
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more